Oslo University Hospital
Oslo, 0607, Norway
Location status: Recruiting
NCT Number: NCT02747771
This study aims at evaluating the effectiveness of group-based cognitive behavioral therapy for trichotillomania at three clinical sites in Norway.
Interested in participating?
Request Info16 year–67 year
All sexes
Observational
Oslo, 0607, Norway
Location status: Recruiting
The Norwegian Trichotillomania Project is a multicenter study that aims at evaluating the effectiveness of behavioral group therapy for TTM, i.e., ACT (Acceptance and commitment therapy) enhanced habit reversal training (ACT-enhanced HRT).
Participants are adults or adolescents (16 year or older) who fulfill criteria for TTM according to DSM-IV. Inclusion started in January 2013 and will be completed by Mai 2016. Treatment is delivered at three treatment sites in Norway; in Kristiansand, Oslo, and Trondheim. Treatment is manualized, following the manual of Twohig and Woods, and consists of ten group sessions of three hours delivered at consecutive weeks, and two or three booster sessions during the first year after treatment.
Treatment outcome is evaluated by three outcome measures; the Massachusetts General Hospital - Hairpulling Scale (self-report); the National Institute of Mental Health Trichotillomania Severity Scale (clinical interview, conducted by independent evaluators); and the Clinical Global Impression Scale for TTM. Outcome is measured at three points in time; at baseline, at the end of treatment, and at one-year follow-up. Mixed models procedures in SPSS is used to analyze longitudinal data.
The first paper will be written on patients admitted to treatment from January 2013 to September 2014, and includes 53 patients (49 women and four men). By January 2016, fifty-one patients (96%) had participated in the one-year follow-up evaluation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
10 sessions Group therapy during 10-12 weeks. The first three sessions focus on habit reversal training, the fourth to sixth session on acceptance and commitment therapy and the last four sessions aims at integrating the two approaches.
Other names: Acceptance and commitment therapy (ACT), Habit reversal training (HRT)
Time frame: baseline, 12 weeks, 12 months
clinical interview
Time frame: baseline, 12 weeks, 12 months
self-report
Time frame: baseline, 12 weeks, 12 months
self-report depressive symptoms
Time frame: baseline, 12 weeks, 12 months
self-report anxiety symptoms
Time frame: baseline, 12 weeks, 12 months
self-reported metacognitions
Time frame: baseline, 12 weeks, 12 months
self-report
Contact information is provided by the study sponsor or research team.
Benjamin Hummelen, Ph.D., M.D.
CONTACT
Erna M Moen, Master
CONTACT
Oslo University Hospital
Other
The Norwegian Trichotillomania Project
Acronym: NorTriP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05118633
Anxiety Disorders, Disruptive, Impulse Control, and Conduct Disorders
Kent, Ohio, United States
View Trial DetailsNCT07224126
Anxiety Disorders, Disruptive, Impulse Control, and Conduct Disorders
Kent, Ohio, United States
View Trial DetailsNCT07282769
Anxiety Disorders, Disruptive, Impulse Control, and Conduct Disorders
View Trial DetailsNCT01075672
Anxiety Disorders, Attention Deficit Disorder with Hyperactivity
Boston, Massachusetts, United States
View Trial Details